The Pharmacological Journey of Etoposide

This chapter explores the pharmacological journey of etoposide, from its origins in the mayapple plant to its clinical application as a topoisomerase II inhibitor. It covers dosage regimens, cancer treatment efficacy, and associated toxicities since its FDA approval in 1983.